A significant advance in cancer research is occurring with the use of mini-antibodies to re-engage mutated p53. This essential malignant inhibitor protein is frequently inactivated in several kinds of tumors, leading https://e-bookmarks.com/story7741855/mini-antibodies-revive-p53-a-new-hope-for-malignant-therapy